Who invested in Excell Biology?
Excell Biology's investors include Matrix Partners China and CICC.

Funding summaryUpdated 26 Oct 2026
$14Mraised across 1 round since 2023, from 1 source
Excell Biology's investors include Matrix Partners China and CICC.
Excell Biology has raised $14M across 1 round since 2023.
Excell Biology's most recent round was a Series B of $14M in May 2023.
Its most recent round, $14M in May 2023, is also its largest on record.
Excell Biology's first round on record, in May 2023, was backed by Matrix Partners China and CICC.
Excell Biology's latest named round is a Series B, in May 2023.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.